Renalytix plc
RNLXY· OTC
RNLXYRenalytix plc
Filed Nov 14, 2023 · 10-Q · 45 days after period end · 0000950170-23-063363
| Metric | Q1 2024 | Q1 2023 |
|---|---|---|
| Revenue | $459.00K | $969.00K |
| Net Income | -$10.15M | -$11.95M |
| EPS Diluted | -$0.11 | -$0.16 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Renalytix plc · CIK 1811115 · Engraved from SEC EDGAR
ended Sep 30, 2023 · filed Nov 14, 2023 · 45 d after period end
